End-stage Renal Disease Clinical Trial
Official title:
Mindfulness for Symptom Reduction: A Transplant Candidate Study in Program Grant Studies of Organ Transplantation in Animals and Man 2P01 DK013083
The purpose of this study is to determine whether telephone-adapted Mindfulness Based Stress Reduction (tMBSR) - a program of mindfulness meditation and gentle Hatha yoga delivered mostly by phone, is an effective program to reduce symptoms (anxiety, depression, sleep) and improve quality of life for people waiting for a kidney transplant. Participants will be randomly assigned to tMBSR or to a support group emphasizing communication skills and selecting resources. Both 8-week programs include an initial in-person meeting, 6 weekly teleconference calls, and conclude with an in-person meeting. Participants will complete questionnaires at 3 timepoints over 6 months, and if they receive a transplant, will complete additional questionnaires. Participants will complete sleep diaries and wear Actiwatches (similar to a wristwatch) for one week before programs start, and when programs end, to measure sleep. Participants will provide saliva samples, over 3 days before programs start, and again when programs end, to measure salivary cortisol, an indicator of stress. tMBSR participants will record daily home meditation practice.
Primary Aims
1. Test the efficacy of a telephone-adapted Mindfulness-Based Stress Reduction (tMBSR)
program to reduce symptoms and improve the quality of life of kidney transplant
candidates by 8-weeks and by 6-month follow-up.
2. Evaluate the impact of tMBSR on sleep measured by actigraphy, and on physiologic
stress, as indicated by alteration in the slope of diurnal salivary cortisols, measured
before and at the end of the 8-week active intervention period.
Secondary Aims
1. Evaluate the impact of tMBSR on perceptions of transplant surgery (treatment
satisfaction, pain) and of Health Related Quality of Life (HRQL) at 2-, 6- and 12-mos
post-transplant surgery.
2. Design a full-scale randomized controlled trial (RCT) of the effectiveness and
cost-effectiveness of tMBSR.
Hypotheses
- Primary: The tMBSR group will report better outcomes than an attention control support
group (SG) on standardized scales for anxiety, depression, and sleep quality and
health-related quality of life at 8 weeks and 6 month follow-up.
- Secondary: The tMBSR group will report better outcomes than the SG group on
actigraphy-derived sleep parameters and diurnal salivary cortisol patterns.
- Tertiary: Candidates who attended mindfulness training will report greater treatment
satisfaction, less distress from pain with transplant surgery and better HRQL 2 months,
6 months and 1 year after kidney transplantation.
Rationale for study : For patients with living with kidney failure, the wait for new kidney
is a stressful time. Pharmacologic therapies for managing symptoms of stress increase risks
for side effects and non-adherence. Mindfulness-based stress reduction (MBSR), a
non-pharmacologic program of training in mindfulness meditation, could help these patients
reduce their symptom distress without increasing these other risks.
Long-range Goal: To develop evidence-based recommendations for non-pharmacologic strategies
that provide symptom relief to transplant patients, and are safe, practical and
cost-effective.
Interventions: The tMBSR program includes the curricular content of the standard 8-week MBSR
program (2002 Instructor's Manual). A trained teacher provides instruction in meditation
techniques including the body-scan, standing, sitting and walking meditations, and gentle
Hatha yoga. Whereas the standard MBSR is conducted as 8 weekly 2.5 hour classes with a one
day retreat between weeks 6 and 7, the telephone-adapted MBSR program begins with 5 hour-day
workshop to introduce the techniques, followed by 6 weekly 1 ½ hour group teleconferences
with the teacher to discuss the class's experiences with meditation practice, and ends with
a 5 hour retreat in week 8. Home practice expectations are 25 minutes per day, 6 days a week
for tMBSR.
The attention control consists of two 90 minute in-person workshops and 6 1-hour
teleconference calls. An experienced facilitator emphasizes communication skills and group
support.
Recruiting Methods:
1. Direct mail to candidates being followed by the Transplant Information Services Office
with follow-up calls; invitation letters and brochures sent from the P01 Clinical Core.
2. Posters and flyers in medical clinics.
3. Referral by health providers - in- service presentations to the pre-transplant
coordinators who manage the kidney candidates;
4. Additional invitations letters mailed by the coordinator who maintains the waitlist for
the United Network for Organ Sharing (UNOS); study brochure or invitation letters
mailed with waitlist acceptance letters.
Potential Measures of intervention 'dose' or enactment:
1. Mindfulness scale: Mindful Awareness Attention Scale (MAAS);
2. Meditation practice time.
Exploratory Outcomes: Post-transplant impact on Quality of Life (QOL) by Short-Form-36
item(SF-36), pain and satisfaction with transplant hospitalization.
Evaluation Methods:
1. Self-report, mailed questionnaires completed at study weeks 0, 8, 26 (primary outcomes
and QOL measures),
2. Actigraphy recording for 1 week prior to the intervention and during the last week of
the intervention; cortisol collection for 3 days during same time periods.
3. Post transplant evaluations - 2 and 6 mos; 1 year coordinated with Transplant Database
Duration of Treatment: 8 weeks
Study Duration: Participants are followed up to one year post-kidney transplant.
Statistical Considerations: This study is powered to compare MBSR and SG, on the primary
endpoint, on the State Trait Anxiety Inventory (STAI), at 8 weeks. Randomization may be
stratified by dialysis (yes/no) and history of diabetes (yes/no).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04087213 -
Study of HemoCareā¢ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD
|
N/A | |
Completed |
NCT02207088 -
Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
|
Phase 3 | |
Not yet recruiting |
NCT03090828 -
Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease
|
N/A | |
Completed |
NCT02237521 -
The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease
|
N/A | |
Withdrawn |
NCT01691196 -
Inflammation in Peritoneal Dialysis Patients: Effect of Obesity
|
||
Completed |
NCT01394341 -
Liraglutide Treatment to Patients With Severe Renal Insufficiency
|
Phase 4 | |
Active, not recruiting |
NCT00247507 -
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
|
Phase 4 | |
Completed |
NCT00307463 -
Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation
|
Phase 4 | |
Recruiting |
NCT00155363 -
Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis
|
Phase 4 | |
Completed |
NCT00234156 -
The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers
|
N/A | |
Completed |
NCT00586131 -
Arterial pH and Total Body Nitrogen Balances in APD
|
Phase 4 | |
Active, not recruiting |
NCT05027074 -
Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)
|
Phase 2 | |
Recruiting |
NCT04575077 -
The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation
|
||
Enrolling by invitation |
NCT05001009 -
Goals of Care Conversations Study
|
N/A | |
Completed |
NCT01756508 -
Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury
|
Phase 2 | |
Recruiting |
NCT03862859 -
The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
|
Phase 4 | |
Terminated |
NCT03661229 -
Cardiovascular and Respiratory Assessment Using Biometric Signals in a Non-contact Monitoring Device
|
N/A | |
Completed |
NCT03288922 -
Protein-bound Toxin Removal Between Limited Blood Flow Super High-flux Online HDF and High-Efficiency Online HDF
|
N/A | |
Completed |
NCT02572882 -
Gut Microbiome and p-Inulin in Hemodialysis
|
N/A | |
Completed |
NCT02360748 -
A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients
|
N/A |